This document discusses key regulatory considerations for medical device approval in major markets. It provides an overview of regulatory strategies and approval processes in the US, EU, Canada and other countries. Major topics covered include device classification systems, premarket approval requirements, quality management standards, clinical data requirements and post-market obligations. Common mistakes made by companies and the importance of developing a comprehensive regulatory strategy early on are also addressed.